Who owns the LogoMark trademark?

The LogoMark trademark is owned by Theravance Biopharma Ireland Limited.

What is the serial number for LogoMark?

The USPTO serial number for LogoMark is 79323261.

What is the registration number for LogoMark?

LogoMark is registered under USPTO registration number 7152676.

LOG

USPTO Trademark Record

REGISTERED

LogoMark

Q: What class is the LogoMark trademark registered in?

The LogoMark trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79323261·Reg 7152676·Filed Jul 15, 2021

Owner Theravance Biopharma Ireland Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

LogoMark (Serial No. 79323261), Registration No. 7152676, is a registered US trademark filed on Jul 15, 2021 by Theravance Biopharma Ireland Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: September 05, 2029

Mark Intelligence

LogoMark (Reg. #7152676) is a registered US trademark that has been protecting its owner, Theravance Biopharma Ireland Limited, since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 6 opposition proceedings during prosecution.

FILED

Jul 15, 2021

SERIAL

79323261

REG#

7152676

REGISTERED

Sep 05, 2023

Owner

Applicant

Theravance Biopharma Ireland Limited

Entity

Not Provided

Address

10 Earlsfort Terrace,, Dublin 2 D02 T380

Country

Attorney

NameBeth H. Alter

Law firm

Beth H. Alter Seward & Kissel LLP

Address

One Battery Park Plaza, New York, NY 10004, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJul 15, 2021

Serial Number79323261

Registration No.7152676

Registration DateSep 05, 2023

Status DateSep 05, 2023

Published for OppositionJun 20, 2023

Mark TypeDesign only

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 6× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

36 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Dec 26, 2023

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Dec 06, 2023

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Dec 05, 2023

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

FINAL DISPOSITION PROCESSED

Dec 05, 2023

FINAL DISPOSITION PROCESSED

REGISTERED-PRINCIPAL REGISTER

Sep 05, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 05, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jul 23, 2023

CHANGE OF NAME/ADDRESS REC'D FROM IB

PUBLISHED FOR OPPOSITION

Jun 20, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 20, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Jun 19, 2023

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 31, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

May 31, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

May 31, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

EXAMINERS AMENDMENT -WRITTEN

May 17, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 17, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 17, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 17, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 17, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Apr 12, 2023

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Mar 22, 2023

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 22, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

FINAL REFUSAL WRITTEN

Dec 01, 2022

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Dec 01, 2022

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Dec 01, 2022

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 03, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 02, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 02, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

Jun 13, 2022

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

May 24, 2022

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 24, 2022

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Apr 19, 2022

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Apr 18, 2022

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 06, 2022

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Oct 27, 2021

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 23, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 22, 2021

SN ASSIGNED FOR SECT 66A APPL FROM IB

LogoMark

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Theravance Biopharma Ireland Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Beth H. Alter

Resources

Company